Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Addex Therapeutics Addex’s Partner Discontinues ADX71149 development in Epilepsy July 22, 2024 From Addex Therapeutics Via GlobeNewswire Addex Presents Positive Results from GABAB PAM Cough Program at the Thirteenth London International Cough Symposium (13th LICS) July 15, 2024 From Addex Therapeutics Via GlobeNewswire Addex To Present at the Thirteenth London International Cough Symposium (13th LICS) July 12, 2024 From Addex Therapeutics Via GlobeNewswire Addex Shareholders Approve All Resolutions at Annual General Meeting July 01, 2024 From Addex Therapeutics Via GlobeNewswire Addex Therapeutics Reports Q1 2024 Financial Results and Provides Corporate Update June 06, 2024 From Addex Therapeutics Via GlobeNewswire Addex Convenes Annual General Meeting 2024 June 05, 2024 From Addex Therapeutics Via GlobeNewswire Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024 May 31, 2024 From Addex Therapeutics Via GlobeNewswire Addex to Present at Bio€quity Europe 2024 May 08, 2024 From Addex Therapeutics Via GlobeNewswire Addex Provides Update on ADX71149 Phase 2 Epilepsy Study April 29, 2024 From Addex Therapeutics Via GlobeNewswire Addex to Present at the Swiss Biotech Day 2024 April 19, 2024 From Addex Therapeutics Via GlobeNewswire Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update April 18, 2024 From Addex Therapeutics Via GlobeNewswire Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024 April 11, 2024 From Addex Therapeutics Via GlobeNewswire Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders April 03, 2024 From Addex Therapeutics Via GlobeNewswire Addex to Present at the Bio-Europe Spring 2024 Conference March 14, 2024 From Addex Therapeutics Via GlobeNewswire Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC. January 31, 2024 From Addex Therapeutics Via GlobeNewswire Addex to Present at the Swiss Equities Baader Conference January 09, 2024 From Addex Therapeutics Via GlobeNewswire Addex to Present at Biotech Showcase™ 2024 January 05, 2024 From Addex Therapeutics Via GlobeNewswire Addex Shareholders Approve All Resolutions at Extraordinary General Meeting December 20, 2023 From Addex Therapeutics Via GlobeNewswire Addex Creates Treasury Shares December 14, 2023 From Addex Therapeutics Via GlobeNewswire Addex Reports Q3 2023 Financial Results and Provides Corporate Update November 29, 2023 From Addex Therapeutics Via GlobeNewswire Addex Convenes Extraordinary General Meeting November 28, 2023 From Addex Therapeutics Via GlobeNewswire Addex Therapeutics to Release Third Quarter 2023 Financial Results and Host Conference Call on November 29, 2023 November 23, 2023 From Addex Therapeutics Via GlobeNewswire Addex ADX71149 Epilepsy Phase 2 Study Completes Recruitment of Patients November 14, 2023 From Addex Therapeutics Via GlobeNewswire Addex Regains Nasdaq Listing Compliance November 08, 2023 From Addex Therapeutics Via GlobeNewswire Addex Announces Participation in the Bio-Europe 2023 Conference November 02, 2023 From Addex Therapeutics Via GlobeNewswire Addex Completes ADS Ratio Change October 20, 2023 From Addex Therapeutics Via GlobeNewswire Addex Announces Plan to Implement ADS Ratio Change October 06, 2023 From Addex Therapeutics Via GlobeNewswire Addex mGlu2 NAM Cognition Program Receives €4 Million Grant September 20, 2023 From Addex Therapeutics Via GlobeNewswire Addex Announces Participation in the H.C. Wainwright 25th Annual Global Investment Conference September 06, 2023 From Addex Therapeutics Via GlobeNewswire Addex ADX71149 Phase 2 Epilepsy Study Expected to Readout Data in Q2 2024 September 05, 2023 From Addex Therapeutics Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.